Adherence to European guidelines in treatment and management of pancreatic exocrine insufficiency in chronic pancreatitis patients

Pancreatology ◽  
2021 ◽  
Vol 21 ◽  
pp. S25-S26
Author(s):  
M. Khan ◽  
W. Rutkowski ◽  
M. Vujasinovic ◽  
W. Jebril ◽  
M. Löhr
Keyword(s):  
Chronic Pancreatitis ◽  
Pancreatic Exocrine Insufficiency ◽  
Exocrine Insufficiency ◽  
European Guidelines ◽  
Pancreatic Exocrine

scholarly journals Adherence to European Guidelines for Treatment and Management of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis Patients

2021 ◽  
Vol 10 (12) ◽  
pp. 2737
Author(s):  
Mashroor Khan ◽  
Wiktor Rutkowski ◽  
Miroslav Vujasinovic ◽  
Johannes Matthias Löhr
Keyword(s):  
Chronic Pancreatitis ◽  
Linear Regression Analysis ◽  
University Hospital ◽  
Diagnosis And Treatment ◽  
Pancreatic Exocrine Insufficiency ◽  
Exocrine Insufficiency ◽  
European Guidelines ◽  
Significant Difference ◽  
Pancreatic Exocrine ◽  
Evidence Based Guidelines

European evidence-based guidelines for the treatment and management of chronic pancreatitis (CP) have been made available following the harmonizing diagnosis and treatment of CP across Europe (HaPanEU) initiative by the United European Gastroenterology (UEG). The aim of this study was to evaluate adherence to the guideline recommendations in the management of patients with pancreatic exocrine insufficiency (PEI) at Karolinska University Hospital in Stockholm. UEG guideline recommendations were evaluated and categorized into 55 different quality indicators (QIs). Data from a retrospective cohort of CP patients being treated at Karolinska University Hospital were evaluated with regard to overall adherence as well as adherence to specific QIs. A total number of 118 patients out of 956 patients diagnosed with CP were eligible for inclusion with mean overall adherence of 61.9% to the defined QIs. A significant difference in mean overall adherence was shown between patients diagnosed with CP prior to 1 January 2016 and following 1 January 2016 (59.3% and 67.7% respectively, p = 0.004), with linear regression analysis also demonstrating improvement correlating to date of diagnosis (p = 0.002). In conclusion, diagnosis and treatment of PEI improved after the HaPanEU guidelines became available and is continuously improving; however, there is room for further improvement.

Cardiovascular risk (CVR) associated with pancreatic exocrine insufficiency (PEI) in patients with chronic pancreatitis (CP)

Pancreatology ◽  
2016 ◽  
Vol 16 (3) ◽  
pp. S80 ◽  
Author(s):  
Nicolau Vallejo-Senra ◽  
Daniel De la Iglesia-García ◽  
Andrea López-López ◽  
Julio Iglesias-Garcia ◽  
Laura Nieto-García ◽  
...  
Keyword(s):  
Chronic Pancreatitis ◽  
Cardiovascular Risk ◽  
Pancreatic Exocrine Insufficiency ◽  
Exocrine Insufficiency ◽  
Pancreatic Exocrine

Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain

2017 ◽  
Vol 32 (11) ◽  
pp. 1813-1817 ◽  
Author(s):  
Nicholas J Talley ◽  
Gerald Holtmann ◽  
Quoc Nam Nguyen ◽  
Peter Gibson ◽  
Peter Bampton ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Chronic Pancreatitis ◽  
Pancreatic Exocrine Insufficiency ◽  
Exocrine Insufficiency ◽  
Pancreatic Exocrine

Increased Postprandial Response of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

Pancreatology ◽  
2010 ◽  
Vol 10 (2-3) ◽  
pp. 201-207 ◽  
Author(s):  
Mads Hornum ◽  
Jan F. Pedersen ◽  
Steen Larsen ◽  
Ole Olsen ◽  
Jens J. Holst ◽  
...  
Keyword(s):  
Chronic Pancreatitis ◽  
Pancreatic Exocrine Insufficiency ◽  
Exocrine Insufficiency ◽  
Postprandial Response ◽  
Pancreatic Exocrine ◽  
Glucagon Like Peptide
Sign in / Sign up

Export Citation Format

Share Document